Cargando…

The relationship between abdominal fat and change in left ventricular ejection fraction in cancer patients

OBJECTIVES: Prior studies have identified a relationship between body mass index (BMI) and intraperitoneal (IP) fat with heart failure; however, in prior studies of cancer patients receiving potentially cardiotoxic chemotherapy, elevations in BMI have not necessarily been associated with decrements...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reding, Kerryn W., Ghemigian, Khristine, Carbone, Salvatore, D'Agostino, Ralph, Jordan, Jennifer H., Meléndez, Giselle, Lamar, Zanetta S., Klepin, Heidi D., Thomas, Alexandra, Langford, Dale, Vasu, Sujethra, Hundley, W. Gregory
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909597/ https://www.ncbi.nlm.nih.gov/pubmed/33680495 http://dx.doi.org/10.1002/osp4.454

Ejemplares similares

Simultaneous Left Ventricular Volume and Strain Changes During Chemotherapy Associate With 2‐Year Postchemotherapy Measures of Left Ventricular Ejection Fraction
por: Suerken, Cynthia K., et al.
Publicado: (2020)

Increased skeletal intermuscular fat is associated with reduced exercise capacity in cancer survivors: a cross-sectional study
por: Reding, Kerryn W., et al.
Publicado: (2019)

Intermuscular Fat Changes Are Related to Reduced Left Ventricular Ejection Fraction During Cancer Therapy (PREVENT-WF-98213)
por: Bellissimo, Moriah P., et al.
Publicado: (2023)

Chronic Statin Administration May Attenuate Early Anthracycline Associated Declines in Left Ventricular Ejection Function
por: Chotenimitkhun, Runyawan, et al.
Publicado: (2014)

Dispersion of hyperenhancement in late gadolinium enhancement cardiovascular magnetic resonance measured with Moran's I is associated with a decrement in LVEF 6 months after cardiotoxic chemotherapy
por: Jordan, Jennifer H, et al.
Publicado: (2013)

Atorvastatin Does Not Attenuate Aortic Stiffening After Doxorubicin for Breast Cancer and Lymphoma (PREVENT-WF-98213)
por: Lucas, Alexander R., et al.
Publicado: (2023)

Fatigue, Cardiovascular Decline, and Events after Breast Cancer Treatment: Rationale and Design of UPBEAT Study
por: Jordan, Jennifer H., et al.
Publicado: (2020)

Understanding cardiovascular injury after treatment for cancer: an overview of current uses and future directions of cardiovascular magnetic resonance
por: Vasu, Sujethra, et al.
Publicado: (2013)

Both intermuscular fat and LVEF decline promote heart failure symptoms in cancer survivors
por: Reding, Kerryn W., et al.
Publicado: (2021)

Gadolinium enhanced magnetic resonance mean voxel signal intensity within the left ventricular myocardium changes prior to ejection fraction drop after receipt of cardiotoxic chemotherapy
por: Lightfoot, Jimmy C, et al.
Publicado: (2009)

Dobutamine induced changes in aortic stiffness: influence of obesity in middle aged and elderly individuals with hypertension, diabetes or coronary artery disease
por: Vasu, Sujethra, et al.
Publicado: (2013)

Automated assessments of circumferential strain from cine CMR correlate with LVEF declines in cancer patients early after receipt of cardio-toxic chemotherapy
por: Jolly, Marie-Pierre, et al.
Publicado: (2017)

Cardiovascular Magnetic Resonance in the Oncology Patient
por: Jordan, Jennifer H., et al.
Publicado: (2018)

Myocardial Function in Premenopausal Women Treated With Ovarian Function Suppression and an Aromatase Inhibitor
por: Jordan, Jennifer H, et al.
Publicado: (2021)

Cardiovascular Assessment Tool for Breast Cancer Survivors and Oncology Providers: Usability Study
por: Weaver, Kathryn E, et al.
Publicado: (2021)

Left atrial stiffness predicts cardiac events in patients with heart failure and reduced ejection fraction: The impact of diabetes
por: Bytyçi, Ibadete, et al.
Publicado: (2021)

Cancer and Its Association With the Development of Coronary Artery Calcification: An Assessment From the Multi‐Ethnic Study of Atherosclerosis
por: Whitlock, Matthew C., et al.
Publicado: (2015)

Effects of Exercise on Heart Failure with Preserved Ejection Fraction: An Updated Review of Literature
por: Crisci, Giulia, et al.
Publicado: (2022)

Abnormal Stress‐Related Measures of Arterial Stiffness in Middle‐Aged and Elderly Men and Women With Impaired Fasting Glucose at Risk for a First Episode of Symptomatic Heart Failure
por: Vasu, Sujethra, et al.
Publicado: (2015)

Left atrial structural and mechanical remodelling in heart failure with reduced ejection fraction
por: Rossi, Andrea, et al.
Publicado: (2021)

Sarcopenic Obesity in Heart Failure With Preserved Ejection Fraction
por: Kirkman, Danielle L., et al.
Publicado: (2020)

Abnormal left ventricular subendocardial perfusion and diastolic function in women with obesity and heart failure and preserved ejection fraction
por: Markley, Roshanak, et al.
Publicado: (2023)

Safety and Tolerability of Nicotinamide Riboside in Heart Failure With Reduced Ejection Fraction
por: Wang, Dennis D., et al.
Publicado: (2022)

Three-dimensional changes in left atrial volumes and ejection fraction during dobutamine stress Cardiovascular Magnetic Resonance
por: Jeevanantham, Vinodh, et al.
Publicado: (2009)

Predictive Value of Collagen Biomarkers for Heart Failure With and Without Preserved Ejection Fraction: MESA (Multi‐Ethnic Study of Atherosclerosis)
por: Duprez, Daniel A., et al.
Publicado: (2018)

Speckle Tracking-Derived Left Atrial Stiffness Predicts Clinical Outcome in Heart Failure Patients with Reduced to Mid-Range Ejection Fraction
por: Bytyçi, Ibadete, et al.
Publicado: (2020)

Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk
por: Miller, Robert J.H., et al.
Publicado: (2022)

Association of aortic wall thickness with stiffness in the Multi-Ethnic Study of Atherosclerosis (MESA)
por: Liu, Chia-Ying, et al.
Publicado: (2014)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
por: Liu, Dan, et al.
Publicado: (2023)

Toward a More Precise Understanding of Obesity and Cancer and Cardiovascular Disease Risk
por: Reding, Kerryn W., et al.
Publicado: (2022)

Asymptomatic myocardial ischemia forecasts adverse events in cardiovascular magnetic resonance dobutamine stress testing of high-risk middle-aged and elderly individuals
por: Stacey, R. Brandon, et al.
Publicado: (2018)

Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis
por: Zhang, Xinxin, et al.
Publicado: (2021)

Chemotherapy induced abnormal aortic function assessed by magnetic resonance imaging
por: Chaosuwannakit, Narumol, et al.
Publicado: (2009)

Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World Experience from Italy (the REAL.IT Study)
por: Di Lenarda, Andrea, et al.
Publicado: (2023)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

Mechanism of decreased sensitivity of dobutamine associated left ventricular wall motion analyses for appreciating inducible ischemia in older adults
por: Vasu, Sujethra, et al.
Publicado: (2015)

Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction
por: Nauta, J. F., et al.
Publicado: (2021)

Diabetes Associated With Greater Ejection Fraction Improvement After Revascularization in Patients With Reduced Ejection Fraction
por: Wang, Shaoping, et al.
Publicado: (2021)

Heart Failure with Reduced Ejection Fraction: The Role of Cardiovascular and Lung Ultrasound beyond Ejection Fraction
por: Shahnazaryan, Syuzanna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8oi4p7prh1tqh7gh1atu32mh17